Browsing by Author O'Connell, Rachel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 32  next >
Issue DateTitleAuthor(s)Citation
2014A 5-Year Review of Gynaecological Oncology Patients Managed by a Fast Track Surgery ProgramCarter, Jonathan; O'Connell, Rachel; Philp, Shannon; Central Clinical School: Obstetrics & Gynaecology; School of Public Health: NH&MRC Clinical Trials Centre; Clinical NursingA 5-Year Review of Gynaecological Oncology Patients Managed by a Fast Track Surgery Program, International Journal of Clinical Medicine, vol.5, 1, 2014,pp 36-41
2017Baseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD studyBarter, Philip; Januszewski, Andrzej Szczesny; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Ong, Kwok; Rye, Kerry-Anne; Simes, Veronica; Waldman, Boris; Best, J; Colman, P; Scott, R; Sullivan, D; Taskinen, Marja-Riitta; Xu, A; Central Clinical School: Heart Research Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Plant & Food Sciences; NH&MRC Clinical Trials CentreBaseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD study, Clinical Chemistry, vol.63, 7, 2017,pp 1261-1270
2016The D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancerArmstrong, Bruce; O'Connell, Rachel; Baxter, Catherine; Duarte Romero, B.; Ebeling, Peter R; English, Dallas; Kimlin, Michael G.; McLeod, Donald S A; Neale, Rachel E; Van Der Pols, Jolieke C.; Venn, Alison; Webb, Penelope M.; Whiteman, David C; Wockner, Leesa; School of Public Health: Public Health; NH&MRC Clinical Trials CentreThe D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancer, Contemporary Clinical Trials, vol.48, N/A, 2016,pp 83-90
2016The D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancerArmstrong, Bruce; O'Connell, Rachel; Baxter, Catherine; Duarte Romero, B.; Ebeling, Peter R; English, Dallas; Kimlin, Michael G.; McLeod, Donald S A; Neale, Rachel E; Van Der Pols, Jolieke C.; Venn, Alison; Webb, Penelope M.; Whiteman, David C; Wockner, Leesa; School of Public Health: Public Health; NH&MRC Clinical Trials CentreThe D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancer, Contemporary Clinical Trials, vol.48, N/A, 2016,pp 83-90
2014Detection of Primary Melanoma in Individuals at Extreme High Risk: A Prospective 5-year Follow-up StudyCoates, Elliot; Guitera, Pascale Andree; Haass, Nikolas; Ho, Kenneth; Mann, Graham; Menzies, Scott; Moloney, Fergal; O'Connell, Rachel; Schmid, Helen; Khoury, Ritta; Raudonikis, Leo; Central Clinical School: Medicine; Central Clinical School: Sydney Melanoma Unit; Central Clinical School: Centenary Institute; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Medicine; Dermatology Research Foundat.; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Detection of Primary Melanoma in Individuals at Extreme High Risk: A Prospective 5-year Follow-up Study, JAMA Dermatology, vol.150, 8, 2014,pp 819-827
2014Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit with Chemotherapy for Symptomatic Ovarian CancerButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; Mercieca-Bebber, Rebecca; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Donovan, Heidi; Oza, Amit; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreDevelopment of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit with Chemotherapy for Symptomatic Ovarian Cancer, International Journal of Gynecological Cancer, vol.24, 5, 2014,pp 865-873
2007Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialKeech, Anthony (Tony); Merrifield, Alistair; Mitchell, Ronald (Paul); Moffitt, Mireille; O'Connell, Rachel; Simes, Robert John; Tse, D; Williamson, E; Crimet, D. C.; Davis, T. M. E.; D'Emden, MC; Laatikainen, LT; O'Day, J; Summanen, PA; Taskinen, M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Clinical Ophthal & Eye Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial, The Lancet, vol.370,(9600),2007,pp 1687-1697
2007Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.Beale, Philip; Carter, Candace; Dhillon, Haryana; Heritier, Stephane; Hickie, Ian; O'Connell, Rachel; Simes, Robert John; Stockler, Martin; Wilcken, Nicholas; Abdi, Ehtesham A; Glasgow, Amanda; Goldstein, David; Jefford, Michael; Nowak, Anna K.; Turner, Jane; Wyld, David; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Brain & Mind Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial., Lancet Oncology, vol.8,(7),2007,pp 603-612
2010Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyDonoghoe, Mark; Gebski, Val; Keech, Anthony (Tony); O'Connell, Rachel; Simes, Robert John; Ting, R; Best, J; Davis, T. M. E.; Drury, P.L.; Glasziou, Paul .P.; Jenkins, Alicia J.; Kesaniemi, Y. Antero; Scott, R; Sullivan, D; Whiting, M. J.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study, Diabetologia: clinical and experimental diabetes and metabolism, vol.54, 2,pp 280-290
2015Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trialsKeech, Anthony (Tony); Kirby, Adrienne; O'Connell, Rachel; Blackwell, Lisa; Braunwald, Eugene; Colhoun, Helen; Collins, Rory; Emberson, Jonathan; et al, Various; Fulcher, Jordan; La Rosa, John; Mihaylova, Borislava; Simes, John; Voysey, Merryn; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreEfficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials, The Lancet, vol.385, 9976, 2015,pp 1397-1405
2015Extraprostatic Extension (EPE) of Prostatic Carcinoma: Is its Proximity to Surgical margin or Gleason Score Important?Gupta, Ruta; Horvath, Lisa; Kench, James; O'Connell, Rachel; Barrett, Wade; Delprado, Warwick; Haynes, Anne Marie; Stricker, Phillip D; Turner, Jennifer Jane; School of Medical Sciences: Pathology; Central Clinical School: Medicine; School of Medical Sciences: Pathology; NH&MRC Clinical Trials CentreExtraprostatic Extension (EPE) of Prostatic Carcinoma: Is its Proximity to Surgical margin or Gleason Score Important?, BJU International, vol.116, 3, 2015,pp 343-350
2006Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques.O'Connell, Rachel; Simes, Robert John; Aylward, Philip A.; de Pasquale, Carmen G.; Edmond, John J.; French, John K; HERO-2, I v; Stewart, Ralph A H; White, Harvey D.; Williams, Barbara F.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreFrequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques., The American Journal of Cardiology 2005, vol.97,(7),2006,pp 947-951
2014HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 DiabetesGebski, Val; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Waldman, Boris; Davis, Timothy M. E.; Ng, Martin K C; Scott, Russell; Taskinen, M.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreHDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes, Diabetes Care, vol.37, 8, 2014,pp 2351-2358
2013Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecological Cancer Intergroup Symptom Benefit StudyButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Oza, Amit; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreHope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecological Cancer Intergroup Symptom Benefit Study, The Oncologist, vol.18, 11, 2013,pp 1221-1228
2012The Index of Microcirculatory Resistance Predicts Myocardial Infarction Related to Percutaneous Coronary InterventionChawantanpipat, Chirapan; Keech, Anthony (Tony); Kritharides, Leonard; Ng, Martin; O'Connell, Rachel; Yong, Andy; Fearon, William; Ho, Michael; Shah, Maulik; Concord Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Concord Clinical School: MedicineThe Index of Microcirculatory Resistance Predicts Myocardial Infarction Related to Percutaneous Coronary Intervention, Circulation. Cardiovascular Interventions, vol.5, 4, 2012,pp 515-522
2012Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 DiabetesBarter, Philip; Brown, Christopher; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Ong, Kwok; Rye, Kerry-Anne; Sullivan, David; Xu, Aimin; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Molecular BioscienceLong-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes, Journal of Clinical Endocrinology and Metabolism, vol.97, 12, 2012,pp 4701-4708
2004Making Sense Of Trial Results: Outcomes And Estimation.Gebski, Val; Keech, Anthony (Tony); O'Connell, Rachel; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreMaking Sense Of Trial Results: Outcomes And Estimation., Medical Journal of Australia, vol.180,(3),2004,pp 128-130
2010A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trialsByth Wilson, Karen; Keech, Anthony (Tony); O'Connell, Rachel; Pardy, Christopher; Simes, Robert John; Voysey, Merryn; Best, James; Ehnholm, Christian; Glasziou, Paul; Scott, Russell; Sullivan, David; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreA novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials, P L o S One, vol.5, 1,pp e8580-1-e8580-10
2017Paragon (ANZGOG-0903): Phase 2 study of anastrozole in women with estrogen or progesterone receptorypositive platinum-resistant or -refractory recurrent ovarian cancerBeale, Philip; deFazio, Anna; Friedlander, Michael; Mapagu, Cristina; Martyn, Julie; Mileshkin, Linda; O'Connell, Rachel; Sjoquist, Katrin; Bonaventura, Anthony; Goh, J; Grant, Peter; Hadley, Alison; McNally, Orla; Scurry, James P; Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; Childrens Hospital Westmead: Paediatrics & Child Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreParagon (ANZGOG-0903): Phase 2 study of anastrozole in women with estrogen or progesterone receptorypositive platinum-resistant or -refractory recurrent ovarian cancer, International Journal of Gynecological Cancer, vol.27, 5, 2017,pp 900-906
2016Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trialBlinman, Prunella; Kolodziej, Ilka; O'Connell, Rachel; Stockler, Martin; Wain, Gerard; Brooks, Susan; Capp, A.; et al, Various; Goss, Geraldine; Johnson, Carol; Khaw, Pearly; Mileshkin, Linda; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Obstetrics & GynaecologyPatients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial, British Journal of Cancer, vol.115, 10, 2016,pp 1179-1185